AAX Biotech - About the company
AAX Biotech is a seed company based in Stockholm (Sweden), founded in 2020. It operates as a Developer of immunotherapies for cancer and autoimmune therapies. AAX Biotech has raised $685K in funding from investors like Phase2Phase, KI Holding and Northislet. The company has 3606 active competitors, including 1205 funded and 817 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of immunotherapies for cancer and autoimmune therapies. It offers Seqitope an antibody epitope mapping method, Opti-mAb for CAR-T cells, and bispecific antibodies development for cancer treatment.
- Website
- www.aaxbiotech.com/
- Email ID
- *****@aaxbiotech.com
Key Metrics
Founded Year
2020
Location
Stockholm, Sweden
Stage
Seed
Total Funding
$685K in 2 rounds
Latest Funding Round
Investors
Ranked
717th among 3606 active competitors
Sign up to download AAX Biotech's company profile
AAX Biotech's funding and investors
AAX Biotech has raised a total funding of $685K over 2 rounds. Its first funding round was on Oct 02, 2024. AAX Biotech has 3 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of AAX Biotech:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 19, 2026 | 7513012 | Seed | 3107029 | 8368731 | 4342360 | 2095057 |
Oct 02, 2024 | 8162914 | Seed | 9935218 | 1668778 |
Access funding benchmarks and valuations. Sign up today!View details of AAX Biotech's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AAX Biotech's Competitors and alternates
Top competitors of AAX Biotech include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of AAX Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 74/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
6th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 72/100 | ||
9th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 72/100 | |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
717th |  AAX Biotech 2020, Stockholm (Sweden), Seed | Developer of immunotherapies for cancer and autoimmune therapies | $685K | 48/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on AAX Biotech's competitors? Click here to see the top ones
AAX Biotech's Investments and acquisitions
AAX Biotech has made no investments or acquisitions yet.
Reports related to AAX Biotech
Here is the latest report on AAX Biotech's sector:
News related to AAX Biotech
Filter this listMedia has covered AAX Biotech for a total of 6 events in the last 1 year, 5 of them have been about partnerships.
•
AAX Biotech and Daiichi Sankyo Advance Collaboration on Antibody TechnologyCision•Aug 31, 2026•AAX Biotech, Daiichi Sankyo
•
•
AAX Biotech Receives Investment from Trio Impact InvestTecnomedicina•Feb 19, 2026•AAX Biotech, trioimpactinvest.se
•
AAX Biotech and Vascurie announce new neuro-oncology collaborationPharmaTimes•Jan 20, 2026•AAX Biotech
•
AAX Biotech & ToxoTech Partner to Advance Biotherapeutics for Neurological DisordersCision•Nov 06, 2025•AAX Biotech, Toxotech
•
AAX Biotech Collaborates with Daiichi Sankyo to Evaluate Opti-mAb® TechnologyCision•Oct 22, 2025•AAX Biotech, Daiichi Sankyo
•
•
AAX sets ambitious 2025 targets with revenue goal up to RM4bilThe Star Online•Feb 28, 2025•AAX Biotech
•
AAX Biotech is now securing capital to promote technology development and growthIT Finans•Oct 03, 2024•AAX Biotech
•
AAX Biotech Secures Funding to Drive Technology Development and ExpansionCision•Oct 02, 2024•AAX Biotech, KI Holding, Northislet, Phase2Phase
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about AAX Biotech
Explore our recently published companies
- Hallway Talk - Denver based, 2014 founded, Unfunded company
- Shalom Hills - Gurugram based, 2004 founded, Unfunded company
- The Space Station - Unfunded company
- Ralph van Roosmalen - Unfunded company
- Universidad Virtual Hispanica de Mexico - Mexico based, Unfunded company
- BRANDOW'S FEED & SEED - Oneonta based, 2005 founded, Unfunded company
